Bioventus Inc. (BVS): Operating Income

Annual figures by period end, from SEC filings.

$53.98M
Year ended 2025-12-31
$58.28M
Trailing 12 months to 2026-06-27
+20.5%
5-year compound annual growth
2019-12-31: $31.19M2020-12-31: $21.24M2021-12-31: $12.06M2022-12-31: -$167.23M2023-12-31: -$81.72M2024-12-31: -$15.20M2025-12-31: $53.98M$53.98M
2019-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$53.98Mn/m2026-03-05, From 2025-01-01
2024-12-31-$15.20Mn/m2026-03-05, From 2024-01-01
2023-12-31-$81.72Mn/m2026-03-05, From 2023-01-01
2022-12-31-$167.23Mn/m2025-03-11, From 2022-01-01
2021-12-31$12.06M-43.2%2024-03-12, From 2021-01-01
2020-12-31$21.24M-31.9%2023-03-31, From 2020-01-01
2019-12-31$31.19Mn/a2022-03-11, From 2019-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Bioventus Inc. (BVS)2025-12-31$53.98Mn/m
UFP Technologies Inc (UFPT)2025-12-31$92.34M+14.1%
AtriCure, Inc. (ATRC)2025-12-31-$9.45Mn/m
Glaukos Corp (GKOS)2025-12-31-$199.60Mn/m
NovoCure Ltd (NVCR)2025-12-31-$153.80Mn/m
Artivion, Inc. (AORT)2025-12-31$33.74M-13.2%
iRhythm Holdings, Inc. (IRTC)2025-12-31-$57.41Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31-$82.13Mn/m
Mimedx Group, Inc. (MDXG)2025-12-31$63.89M+8.5%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗